Corcept Therapeutics Pre-Tax Income 2010-2024 | CORT

Corcept Therapeutics pre-tax income for the twelve months ending December 31, 2024 was $0.161B, a 29.65% increase year-over-year.

  • Corcept Therapeutics annual pre-tax income for 2024 was $0.161B, a 29.65% increase from 2023.
  • Corcept Therapeutics annual pre-tax income for 2023 was $0.125B, a 7.2% increase from 2022.
  • Corcept Therapeutics annual pre-tax income for 2022 was $0.116B, a 7.05% decline from 2021.

Corcept Therapeutics Pre-Tax Income 2010-2024 | CORT

  • Corcept Therapeutics annual pre-tax income for 2024 was $0.161B, a 29.65% increase from 2023.
  • Corcept Therapeutics annual pre-tax income for 2023 was $0.125B, a 7.2% increase from 2022.
  • Corcept Therapeutics annual pre-tax income for 2022 was $0.116B, a 7.05% decline from 2021.